查看購物車
  • Simplified Chinese
  • English
  • Japanese
  • Korean
封面
市場調查報告書
商品編碼
1370340

聚合酶鍊式反應市場：2023-2028 年全球產業趨勢、佔有率、規模、成長、機會與預測

Polymerase Chain Reaction Market: Global Industry Trends, Share, Size, Growth, Opportunity and Forecast 2023-2028
出版日期: | 出版商: IMARC | 英文 140 Pages | 商品交期: 2-3個工作天內

價格

概要

2023-2028 年市場概況：

2022年全球聚合酶連鎖反應市場規模達71億美元。展望未來，IMARC Group預計到2028年市場規模將達到109億美元，2023-2028年年複合成長率（CAGR）為7.3%。

聚合酶鍊式反應 (PCR) 是一種分子診斷技術，用於製備 DNA 片段的多個副本。 PCR 機用於在自動和預編程程序中控制樣品的溫度，以準確產生數百萬個 DNA 定序副本。此技術可識別和培養致病微生物，有助於檢測結核病、後天免疫缺乏症候群（愛滋病）、感染和萊姆病。因此，它在各種生命科學相關領域中廣泛應用，例如遺傳學、生物技術、分子生物學、藥物發現和臨床診斷。

全球聚合酶鍊式反應市場趨勢與促進因素：

各種傳染病和遺傳性疾病的日益普及是推動市場成長的關鍵因素之一。全球老年人口不斷增加，更容易罹患慢性病，也推動了該產業的成長。冠狀病毒病（COVID-19）大流行的爆發進一步導致PCR技術的廣泛採用，以準確診斷和早期檢測感染。 PCR 設備還有助於最大限度地減少整個過程中的污染風險和人為錯誤的可能性。

對個人化和精準醫療的需求不斷成長也為市場創造了積極的前景。這些藥物旨在提供量身定做的療法，這些療法是使用 PCR 技術識別和開發的。其他因素，包括臨床診斷應用的增加，以及生物技術領域的廣泛研發（R&D）活動，預計將進一步推動市場發展。

本報告回答的關鍵問題：

  • 迄今為止，全球聚合酶鍊式反應市場表現如何，未來幾年又會如何表現？
  • COVID-19 對全球聚合酶鍊式反應市場有何影響？
  • 主要區域市場有哪些？
  • 基於產品的市場區隔是什麼？
  • 基於最終用戶的市場區隔是什麼？
  • 產業價值鏈的各個階段是什麼？
  • 該行業的關鍵促進因素和挑戰是什麼？
  • 全球聚合酶鍊式反應市場的結構如何？誰是主要參與者？
  • 產業競爭程度如何？

目錄

第 1 章：前言

第 2 章：範圍與方法

  • 研究目的
  • 利害關係人
  • 資料來源
    • 主要資源
    • 二手資料
  • 市場預測
    • 自下而上的方法
    • 自上而下的方法
  • 預測方法

第 3 章：執行摘要

第 4 章：簡介

  • 概述
  • 主要行業趨勢

第 5 章：全球聚合酶鍊式反應市場

  • 市場概況
  • 市場業績
  • COVID-19 的影響
  • 市場預測

第 6 章：按產品分類的市場區隔

  • 儀器
    • 市場走向
    • 按類型分類的市場細分
      • 標準 PCR 系統
        • 市場走向
        • 市場預測
      • 數位 PCR 系統
        • 市場走向
        • 市場預測
      • 即時螢光定量PCR系統
        • 市場走向
        • 市場預測
    • 市場預測
  • 試劑及耗材
    • 市場走向
    • 市場預測
  • 軟體和服務
    • 市場走向
    • 市場預測

第 7 章：最終用戶的市場區隔

  • 學術及研究機構
    • 市場走向
    • 市場預測
  • 臨床診斷實驗室和醫院
    • 市場走向
    • 市場預測
  • 製藥和生物技術公司
    • 市場走向
    • 市場預測
  • 其他
    • 市場走向
    • 市場預測

第 8 章：按地區分類的市場區隔

  • 北美洲
    • 美國
      • 市場走向
      • 市場預測
    • 加拿大
      • 市場走向
      • 市場預測
  • 亞太地區
    • 中國
      • 市場走向
      • 市場預測
    • 日本
      • 市場走向
      • 市場預測
    • 印度
      • 市場走向
      • 市場預測
    • 韓國
      • 市場走向
      • 市場預測
    • 澳洲
      • 市場走向
      • 市場預測
    • 印尼
      • 市場走向
      • 市場預測
    • 其他
      • 市場走向
      • 市場預測
  • 歐洲
    • 德國
      • 市場走向
      • 市場預測
    • 法國
      • 市場走向
      • 市場預測
    • 英國
      • 市場走向
      • 市場預測
    • 義大利
      • 市場走向
      • 市場預測
    • 西班牙
      • 市場走向
      • 市場預測
    • 俄羅斯
      • 市場走向
      • 市場預測
    • 其他
      • 市場走向
      • 市場預測
  • 拉丁美洲
    • 巴西
      • 市場走向
      • 市場預測
    • 墨西哥
      • 市場走向
      • 市場預測
    • 其他
      • 市場走向
      • 市場預測
  • 中東和非洲
    • 市場走向
    • 按國家/地區分類的市場細分
    • 市場預測

第 9 章：SWOT 分析

  • 概述
  • 優勢
  • 弱點
  • 機會
  • 威脅

第 10 章：價值鏈分析

第 11 章：波特五力分析

  • 概述
  • 買家的議價能力
  • 供應商的議價能力
  • 競爭程度
  • 新進入者的威脅
  • 替代品的威脅

第 12 章：價格分析

第13章：競爭格局

  • 市場結構
  • 關鍵參與者
  • 關鍵參與者簡介
    • Agilent Technologies Inc.
    • BD (Becton, Dickinson and Company)
    • BioMerieux (Institut Merieux SA)
    • Bio-RAD Laboratories Inc.
    • F. Hoffmann-La Roche AG
    • Fluidigm Corporation
    • Merck KGaA
    • Perkinelmer Inc.
    • Promega Corporation
    • Takara Bio Inc.
    • Thermo Fisher Scientific Inc.
Product Code: SR112023A2315

Abstract

Market Overview 2023-2028:

The global polymerase chain reaction market size reached US$ 7.1 Billion in 2022. Looking forward, IMARC Group expects the market to reach US$ 10.9 Billion by 2028, exhibiting a growth rate (CAGR) of 7.3% during 2023-2028.

Polymerase chain reaction (PCR) refers to a molecular diagnostic technique that is used to make multiple copies of a segment of DNA. A PCR machine is used to manipulate the temperature of the sample in an automatic and pre-programmed procedure to generate millions of copies of DNA sequencing accurately. This technology identifies and cultures disease-causing microorganisms, which aid in the detection of tuberculosis, Acquired Immunodeficiency Syndrome (AIDS), infections and Lyme disease. Owing to this, it finds extensive applications across various life science-related fields, such as genetics, biotechnology, molecular biology, drug discovery and clinical diagnostics.

Global Polymerase Chain Reaction Market Trends and Drivers:

The increasing prevalence of various infectious diseases and genetic disorders is one of the key factors driving the growth of the market. The rising geriatric population across the globe, which is more prone to chronic medical ailments, is also driving the industry growth. The outbreak of the coronavirus disease (COVID-19) pandemic has further led to the widespread adoption of PCR technologies for accurate diagnosis and early detection of infections. PCR devices also aid in minimizing the risks of contamination and the chances of human errors in the entire process.

The increasing demand for personalized and precision medicines is also creating a positive outlook for the market. These medicines aim to provide tailor-made therapies, which are identified and developed using PCR technologies. Other factors, including the increasing application in clinical diagnostics, along with extensive research and development (R&D) activities in the field of biotechnology, are expected to drive the market further.

Key Market Segmentation:

IMARC Group provides an analysis of the key trends in each segment of the global polymerase chain reaction market report, along with forecasts at the global, regional and country levels from 2023-2028. Our report has categorized the market based on product and end user.

Breakup by Product:

Instruments

Standard PCR Systems

Digital PCR Systems

Real-time PCR Systems

Reagents and Consumables

Software and Services

Breakup by End User:

Academic and Research Institutes

Clinical Diagnostics Labs and Hospitals

Pharmaceutical and Biotechnology Companies

Others

Breakup by Region:

North America

United States

Canada

Asia Pacific

China

Japan

India

South Korea

Australia

Indonesia

Others

Europe

Germany

France

United Kingdom

Italy

Spain

Russia

Others

Latin America

Brazil

Mexico

Others

Middle East and Africa

Competitive Landscape:

The report has also analysed the competitive landscape of the market with some of the key players being Agilent Technologies Inc., BD (Becton, Dickinson and Company), BioMerieux (Institut Merieux SA), Bio-RAD Laboratories Inc., F. Hoffmann-La Roche AG, Fluidigm Corporation, Merck KGaA, Perkinelmer Inc., Promega Corporation, Takara Bio Inc. and Thermo Fisher Scientific Inc.

Key Questions Answered in This Report:

  • How has the global polymerase chain reaction market performed so far and how will it perform in the coming years?
  • What has been the impact of COVID-19 on the global polymerase chain reaction market?
  • What are the key regional markets?
  • What is the breakup of the market based on the product?
  • What is the breakup of the market based on the end user?
  • What are the various stages in the value chain of the industry?
  • What are the key driving factors and challenges in the industry?
  • What is the structure of the global polymerase chain reaction market and who are the key players?
  • What is the degree of competition in the industry?

Table of Contents

1 Preface

2 Scope and Methodology

  • 2.1 Objectives of the Study
  • 2.2 Stakeholders
  • 2.3 Data Sources
    • 2.3.1 Primary Sources
    • 2.3.2 Secondary Sources
  • 2.4 Market Estimation
    • 2.4.1 Bottom-Up Approach
    • 2.4.2 Top-Down Approach
  • 2.5 Forecasting Methodology

3 Executive Summary

4 Introduction

  • 4.1 Overview
  • 4.2 Key Industry Trends

5 Global Polymerase Chain Reaction Market

  • 5.1 Market Overview
  • 5.2 Market Performance
  • 5.3 Impact of COVID-19
  • 5.4 Market Forecast

6 Market Breakup by Product

  • 6.1 Instruments
    • 6.1.1 Market Trends
    • 6.1.2 Market Breakup by Type
      • 6.1.2.1 Standard PCR Systems
        • 6.1.2.1.1 Market Trends
        • 6.1.2.1.2 Market Forecast
      • 6.1.2.2 Digital PCR Systems
        • 6.1.2.2.1 Market Trends
        • 6.1.2.2.2 Market Forecast
      • 6.1.2.3 Real-Time PCR Systems
        • 6.1.2.3.1 Market Trends
        • 6.1.2.3.2 Market Forecast
    • 6.1.3 Market Forecast
  • 6.2 Reagents and Consumables
    • 6.2.1 Market Trends
    • 6.2.2 Market Forecast
  • 6.3 Software and Services
    • 6.3.1 Market Trends
    • 6.3.2 Market Forecast

7 Market Breakup by End User

  • 7.1 Academic and Research Institutes
    • 7.1.1 Market Trends
    • 7.1.2 Market Forecast
  • 7.2 Clinical Diagnostics Labs and Hospitals
    • 7.2.1 Market Trends
    • 7.2.2 Market Forecast
  • 7.3 Pharmaceutical and Biotechnology Companies
    • 7.3.1 Market Trends
    • 7.3.2 Market Forecast
  • 7.4 Others
    • 7.4.1 Market Trends
    • 7.4.2 Market Forecast

8 Market Breakup by Region

  • 8.1 North America
    • 8.1.1 United States
      • 8.1.1.1 Market Trends
      • 8.1.1.2 Market Forecast
    • 8.1.2 Canada
      • 8.1.2.1 Market Trends
      • 8.1.2.2 Market Forecast
  • 8.2 Asia Pacific
    • 8.2.1 China
      • 8.2.1.1 Market Trends
      • 8.2.1.2 Market Forecast
    • 8.2.2 Japan
      • 8.2.2.1 Market Trends
      • 8.2.2.2 Market Forecast
    • 8.2.3 India
      • 8.2.3.1 Market Trends
      • 8.2.3.2 Market Forecast
    • 8.2.4 South Korea
      • 8.2.4.1 Market Trends
      • 8.2.4.2 Market Forecast
    • 8.2.5 Australia
      • 8.2.5.1 Market Trends
      • 8.2.5.2 Market Forecast
    • 8.2.6 Indonesia
      • 8.2.6.1 Market Trends
      • 8.2.6.2 Market Forecast
    • 8.2.7 Others
      • 8.2.7.1 Market Trends
      • 8.2.7.2 Market Forecast
  • 8.3 Europe
    • 8.3.1 Germany
      • 8.3.1.1 Market Trends
      • 8.3.1.2 Market Forecast
    • 8.3.2 France
      • 8.3.2.1 Market Trends
      • 8.3.2.2 Market Forecast
    • 8.3.3 United Kingdom
      • 8.3.3.1 Market Trends
      • 8.3.3.2 Market Forecast
    • 8.3.4 Italy
      • 8.3.4.1 Market Trends
      • 8.3.4.2 Market Forecast
    • 8.3.5 Spain
      • 8.3.5.1 Market Trends
      • 8.3.5.2 Market Forecast
    • 8.3.6 Russia
      • 8.3.6.1 Market Trends
      • 8.3.6.2 Market Forecast
    • 8.3.7 Others
      • 8.3.7.1 Market Trends
      • 8.3.7.2 Market Forecast
  • 8.4 Latin America
    • 8.4.1 Brazil
      • 8.4.1.1 Market Trends
      • 8.4.1.2 Market Forecast
    • 8.4.2 Mexico
      • 8.4.2.1 Market Trends
      • 8.4.2.2 Market Forecast
    • 8.4.3 Others
      • 8.4.3.1 Market Trends
      • 8.4.3.2 Market Forecast
  • 8.5 Middle East and Africa
    • 8.5.1 Market Trends
    • 8.5.2 Market Breakup by Country
    • 8.5.3 Market Forecast

9 SWOT Analysis

  • 9.1 Overview
  • 9.2 Strengths
  • 9.3 Weaknesses
  • 9.4 Opportunities
  • 9.5 Threats

10 Value Chain Analysis

11 Porters Five Forces Analysis

  • 11.1 Overview
  • 11.2 Bargaining Power of Buyers
  • 11.3 Bargaining Power of Suppliers
  • 11.4 Degree of Competition
  • 11.5 Threat of New Entrants
  • 11.6 Threat of Substitutes

12 Price Analysis

13 Competitive Landscape

  • 13.1 Market Structure
  • 13.2 Key Players
  • 13.3 Profiles of Key Players
    • 13.3.1 Agilent Technologies Inc.
      • 13.3.1.1 Company Overview
      • 13.3.1.2 Product Portfolio
      • 13.3.1.3 Financials
      • 13.3.1.4 SWOT Analysis
    • 13.3.2 BD (Becton, Dickinson and Company)
      • 13.3.2.1 Company Overview
      • 13.3.2.2 Product Portfolio
      • 13.3.2.3 Financials
      • 13.3.2.4 SWOT Analysis
    • 13.3.3 BioMerieux (Institut Merieux SA)
      • 13.3.3.1 Company Overview
      • 13.3.3.2 Product Portfolio
      • 13.3.3.3 Financials
      • 13.3.3.4 SWOT Analysis
    • 13.3.4 Bio-RAD Laboratories Inc.
      • 13.3.4.1 Company Overview
      • 13.3.4.2 Product Portfolio
      • 13.3.4.3 Financials
      • 13.3.4.4 SWOT Analysis
    • 13.3.5 F. Hoffmann-La Roche AG
      • 13.3.5.1 Company Overview
      • 13.3.5.2 Product Portfolio
      • 13.3.5.3 Financials
    • 13.3.6 Fluidigm Corporation
      • 13.3.6.1 Company Overview
      • 13.3.6.2 Product Portfolio
      • 13.3.6.3 Financials
    • 13.3.7 Merck KGaA
      • 13.3.7.1 Company Overview
      • 13.3.7.2 Product Portfolio
      • 13.3.7.3 Financials
      • 13.3.7.4 SWOT Analysis
    • 13.3.8 Perkinelmer Inc.
      • 13.3.8.1 Company Overview
      • 13.3.8.2 Product Portfolio
      • 13.3.8.3 Financials
      • 13.3.8.4 SWOT Analysis
    • 13.3.9 Promega Corporation
      • 13.3.9.1 Company Overview
      • 13.3.9.2 Product Portfolio
    • 13.3.10 Takara Bio Inc.
      • 13.3.10.1 Company Overview
      • 13.3.10.2 Product Portfolio
      • 13.3.10.3 Financials
    • 13.3.11 Thermo Fisher Scientific Inc.
      • 13.3.11.1 Company Overview
      • 13.3.11.2 Product Portfolio
      • 13.3.11.3 Financials
      • 13.3.11.4 SWOT Analysis

List of Figures

  • Figure 1: Global: Polymerase Chain Reaction Market: Major Drivers and Challenges
  • Figure 2: Global: Polymerase Chain Reaction Market: Sales Value (in Billion US$), 2017-2022
  • Figure 3: Global: Polymerase Chain Reaction Market: Breakup by Product (in %), 2022
  • Figure 4: Global: Polymerase Chain Reaction Market: Breakup by End User (in %), 2022
  • Figure 5: Global: Polymerase Chain Reaction Market: Breakup by Region (in %), 2022
  • Figure 6: Global: Polymerase Chain Reaction Market Forecast: Sales Value (in Billion US$), 2023-2028
  • Figure 7: Global: Polymerase Chain Reaction (Instruments) Market: Sales Value (in Million US$), 2017 & 2022
  • Figure 8: Global: Polymerase Chain Reaction (Instruments) Market: Breakup by Type (in %), 2022
  • Figure 9: Global: Polymerase Chain Reaction (Instruments- Standard PCR Systems) Market: Sales Value (in Million US$), 2017 & 2022
  • Figure 10: Global: Polymerase Chain Reaction (Instruments- Standard PCR Systems) Market Forecast: Sales Value (in Million US$), 2023-2028
  • Figure 11: Global: Polymerase Chain Reaction (Instruments- Digital PCR Systems) Market: Sales Value (in Million US$), 2017 & 2022
  • Figure 12: Global: Polymerase Chain Reaction (Instruments- Digital PCR Systems) Market Forecast: Sales Value (in Million US$), 2023-2028
  • Figure 13: Global: Polymerase Chain Reaction (Instruments- Real-Time PCR Systems) Market: Sales Value (in Million US$), 2017 & 2022
  • Figure 14: Global: Polymerase Chain Reaction (Instruments- Real-Time PCR Systems) Market Forecast: Sales Value (in Million US$), 2023-2028
  • Figure 15: Global: Polymerase Chain Reaction (Instruments) Market Forecast: Sales Value (in Million US$), 2023-2028
  • Figure 16: Global: Polymerase Chain Reaction (Reagents and Consumables) Market: Sales Value (in Million US$), 2017 & 2022
  • Figure 17: Global: Polymerase Chain Reaction (Reagents and Consumables) Market Forecast: Sales Value (in Million US$), 2023-2028
  • Figure 18: Global: Polymerase Chain Reaction (Software and Services) Market: Sales Value (in Million US$), 2017 & 2022
  • Figure 19: Global: Polymerase Chain Reaction (Software and Services) Market Forecast: Sales Value (in Million US$), 2023-2028
  • Figure 20: Global: Polymerase Chain Reaction (Academic and Research Institutes) Market: Sales Value (in Million US$), 2017 & 2022
  • Figure 21: Global: Polymerase Chain Reaction (Academic and Research Institutes) Market Forecast: Sales Value (in Million US$), 2023-2028
  • Figure 22: Global: Polymerase Chain Reaction (Clinical Diagnostics Labs and Hospitals) Market: Sales Value (in Million US$), 2017 & 2022
  • Figure 23: Global: Polymerase Chain Reaction (Clinical Diagnostics Labs and Hospitals) Market Forecast: Sales Value (in Million US$), 2023-2028
  • Figure 24: Global: Polymerase Chain Reaction (Pharmaceutical and Biotechnology Companies) Market: Sales Value (in Million US$), 2017 & 2022
  • Figure 25: Global: Polymerase Chain Reaction (Pharmaceutical and Biotechnology Companies) Market Forecast: Sales Value (in Million US$), 2023-2028
  • Figure 26: Global: Polymerase Chain Reaction (Other End Users) Market: Sales Value (in Million US$), 2017 & 2022
  • Figure 27: Global: Polymerase Chain Reaction (Other End Users) Market Forecast: Sales Value (in Million US$), 2023-2028
  • Figure 28: North America: Polymerase Chain Reaction Market: Sales Value (in Million US$), 2017 & 2022
  • Figure 29: North America: Polymerase Chain Reaction Market Forecast: Sales Value (in Million US$), 2023-2028
  • Figure 30: United States: Polymerase Chain Reaction Market: Sales Value (in Million US$), 2017 & 2022
  • Figure 31: United States: Polymerase Chain Reaction Market Forecast: Sales Value (in Million US$), 2023-2028
  • Figure 32: Canada: Polymerase Chain Reaction Market: Sales Value (in Million US$), 2017 & 2022
  • Figure 33: Canada: Polymerase Chain Reaction Market Forecast: Sales Value (in Million US$), 2023-2028
  • Figure 34: Asia Pacific: Polymerase Chain Reaction Market: Sales Value (in Million US$), 2017 & 2022
  • Figure 35: Asia Pacific: Polymerase Chain Reaction Market Forecast: Sales Value (in Million US$), 2023-2028
  • Figure 36: China: Polymerase Chain Reaction Market: Sales Value (in Million US$), 2017 & 2022
  • Figure 37: China: Polymerase Chain Reaction Market Forecast: Sales Value (in Million US$), 2023-2028
  • Figure 38: Japan: Polymerase Chain Reaction Market: Sales Value (in Million US$), 2017 & 2022
  • Figure 39: Japan: Polymerase Chain Reaction Market Forecast: Sales Value (in Million US$), 2023-2028
  • Figure 40: India: Polymerase Chain Reaction Market: Sales Value (in Million US$), 2017 & 2022
  • Figure 41: India: Polymerase Chain Reaction Market Forecast: Sales Value (in Million US$), 2023-2028
  • Figure 42: South Korea: Polymerase Chain Reaction Market: Sales Value (in Million US$), 2017 & 2022
  • Figure 43: South Korea: Polymerase Chain Reaction Market Forecast: Sales Value (in Million US$), 2023-2028
  • Figure 44: Australia: Polymerase Chain Reaction Market: Sales Value (in Million US$), 2017 & 2022
  • Figure 45: Australia: Polymerase Chain Reaction Market Forecast: Sales Value (in Million US$), 2023-2028
  • Figure 46: Indonesia: Polymerase Chain Reaction Market: Sales Value (in Million US$), 2017 & 2022
  • Figure 47: Indonesia: Polymerase Chain Reaction Market Forecast: Sales Value (in Million US$), 2023-2028
  • Figure 48: Others: Polymerase Chain Reaction Market: Sales Value (in Million US$), 2017 & 2022
  • Figure 49: Others: Polymerase Chain Reaction Market Forecast: Sales Value (in Million US$), 2023-2028
  • Figure 50: Europe: Polymerase Chain Reaction Market: Sales Value (in Million US$), 2017 & 2022
  • Figure 51: Europe: Polymerase Chain Reaction Market Forecast: Sales Value (in Million US$), 2023-2028
  • Figure 52: Germany: Polymerase Chain Reaction Market: Sales Value (in Million US$), 2017 & 2022
  • Figure 53: Germany: Polymerase Chain Reaction Market Forecast: Sales Value (in Million US$), 2023-2028
  • Figure 54: France: Polymerase Chain Reaction Market: Sales Value (in Million US$), 2017 & 2022
  • Figure 55: France: Polymerase Chain Reaction Market Forecast: Sales Value (in Million US$), 2023-2028
  • Figure 56: United Kingdom: Polymerase Chain Reaction Market: Sales Value (in Million US$), 2017 & 2022
  • Figure 57: United Kingdom: Polymerase Chain Reaction Market Forecast: Sales Value (in Million US$), 2023-2028
  • Figure 58: Italy: Polymerase Chain Reaction Market: Sales Value (in Million US$), 2017 & 2022
  • Figure 59: Italy: Polymerase Chain Reaction Market Forecast: Sales Value (in Million US$), 2023-2028
  • Figure 60: Spain: Polymerase Chain Reaction Market: Sales Value (in Million US$), 2017 & 2022
  • Figure 61: Spain: Polymerase Chain Reaction Market Forecast: Sales Value (in Million US$), 2023-2028
  • Figure 62: Russia: Polymerase Chain Reaction Market: Sales Value (in Million US$), 2017 & 2022
  • Figure 63: Russia: Polymerase Chain Reaction Market Forecast: Sales Value (in Million US$), 2023-2028
  • Figure 64: Others: Polymerase Chain Reaction Market: Sales Value (in Million US$), 2017 & 2022
  • Figure 65: Others: Polymerase Chain Reaction Market Forecast: Sales Value (in Million US$), 2023-2028
  • Figure 66: Latin America: Polymerase Chain Reaction Market: Sales Value (in Million US$), 2017 & 2022
  • Figure 67: Latin America: Polymerase Chain Reaction Market Forecast: Sales Value (in Million US$), 2023-2028
  • Figure 68: Brazil: Polymerase Chain Reaction Market: Sales Value (in Million US$), 2017 & 2022
  • Figure 69: Brazil: Polymerase Chain Reaction Market Forecast: Sales Value (in Million US$), 2023-2028
  • Figure 70: Mexico: Polymerase Chain Reaction Market: Sales Value (in Million US$), 2017 & 2022
  • Figure 71: Mexico: Polymerase Chain Reaction Market Forecast: Sales Value (in Million US$), 2023-2028
  • Figure 72: Others: Polymerase Chain Reaction Market: Sales Value (in Million US$), 2017 & 2022
  • Figure 73: Others: Polymerase Chain Reaction Market Forecast: Sales Value (in Million US$), 2023-2028
  • Figure 74: Middle East and Africa: Polymerase Chain Reaction Market: Sales Value (in Million US$), 2017 & 2022
  • Figure 75: Middle East and Africa: Polymerase Chain Reaction Market Forecast: Sales Value (in Million US$), 2023-2028
  • Figure 76: Global: Polymerase Chain Reaction Industry: SWOT Analysis
  • Figure 77: Global: Polymerase Chain Reaction Industry: Value Chain Analysis
  • Figure 78: Global: Polymerase Chain Reaction Industry: Porter's Five Forces Analysis

List of Tables

  • Table 1: Global: Polymerase Chain Reaction Market: Key Industry Highlights, 2022 and 2028
  • Table 2: Global: Polymerase Chain Reaction Market Forecast: Breakup by Product (in Million US$), 2023-2028
  • Table 3: Global: Polymerase Chain Reaction Market Forecast: Breakup by End User (in Million US$), 2023-2028
  • Table 4: Global: Polymerase Chain Reaction Market Forecast: Breakup by Region (in Million US$), 2023-2028
  • Table 5: Global: Polymerase Chain Reaction Market Structure
  • Table 6: Global: Polymerase Chain Reaction Market: Key Players